American College of Emergency Physicians (ACEP)
American Academy of Neurology (AAN)
- Antiepileptic drug selection for people with HIV/AIDS (2012; reaffirmed 2024)
- Antiseizure Medication Withdrawal in Seizure-Free Patients: Practice Advisory Update Summary (2021)
- Evidence-based guideline: Management of an unprovoked first seizure in adults (2015; reaffirmed 2024)
- Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (2009; reaffirmed 2022)
- Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (2015)
- Practice parameter: Treatment of the child with a first unprovoked seizure (2003; reaffirmed 2024)
- Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication (2024)
- The use of Felbamate in the treatment of patients with intractable epilepsy (1999; reaffirmed 2025)
- Update: Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New-onset Epilepsy (2018; reaffirmed 2024)
- Update: Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-resistant Epilepsy (2018; reaffirmed 2024)
American Epilepsy Society (AES)
- Treatment of refractory convulsive status epilepticus (2020)
- Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults (2016)
International League Against Epilepsy (ILAE)
- Barriers to generic antiseizure medication use: results of a global survey by the International League Against Epilepsy Generic Substitution Task Force (2022)
- FDA safety warning on the cardiac effects of lamotrigine: an advisory from the Ad Hoc ILAE/AES Task Force (2021)
- Management of epilepsy in pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy (2019)
- Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes (2013)
- Antiepileptic drugs and suicidality: An expert consensus statement (2013)
- Antiepileptic drugs – Best practice guidelines for therapeutic drug monitoring (2008)
National Institute for Health and Care Excellence (NICE)
- Epilepsies in Children Young People and Adults (2022, reaffirmed 2025)
- Cannabis-based medicinal products (2019; updated 2021)
Neurocritical Care Society
- Guidelines for seizure prophylaxis in patients hospitalized with nontraumatic intracerebral hemorrhage: a clinical practice guideline for health care professionals rom the neurocritical care society (2024)
- Guidelines for seizure prophylaxis in adults hospitalized with moderate-severe traumatic brain injury: a clinical practice guideline for health care professionals from the neurocritical care society (2024)
- Guidelines for the evaluation and management of status epilepticus (2012)
Reviewer 1: Maria Blaze, PharmD, BCPP
Reviewer 2: Austin Smith, PharmD, BCPP
2025-2026 AAPP Resident and New Practitioner Committee